Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

RimAsia Capital Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$45M
Portfolio companies 2
Rounds per year 0.12
Lead investments 1
Exits 2
Key employees 2

Areas of investment

  • Hardware
  • Manufacturing
  • Software
  • Pharmaceutical
  • Biotechnology
Summary

RimAsia Capital Partners is the famous VC, which was founded in 2004. The fund was located in Asia if to be more exact in Hong Kong. The leading representative office of defined VC is situated in the Wan Chai.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Caladrius Biosciences. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Software, Biotechnology.

The overall number of key employees were 2.

The important activity for fund was in 2009. The top amount of exits for fund were in 2000. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The usual cause for the fund is to invest in rounds with 3-4 partakers. The meaningful sponsors for the fund in investment in the same round are Shanghai Industrial Holdings, New Enterprise Associates, Intel Capital. In the next rounds fund is usually obtained by National Institutes of Health.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anhui Hongye Guanli Anhui, China, Hefei
Citi Singapore Central, Central Region, Singapore
CoinUs -
Druid BioVentures Pennsylvania, Philadelphia, United States
Equity 38 Atlanta, Georgia, United States
Hangzhou Economic Development Zone Capital China, Hangzhou, Zhejiang
kipleX Kuala Lumpur, Malaysia
Martin Global AG Buchs, Inner-Rhoden, Switzerland
Tamiami Angel Funds Florida, Naples, United States
UDC Ventures New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Actions Semiconductor

Hardware
Manufacturing
Software
$80M16 Sep 2005 Huizhou, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent RimAsia Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 45M
Rounds per year 0.12
Peak activity year 2005
Lead investments 1
Exits 2
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Actions Semiconductor

Hardware
Manufacturing
Software
$80M16 Sep 2005 Huizhou, Guangdong Province, China
Crunchbase icon

Content report

The following text will be sent to our editors: